No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Bright Minds Initiated at Outperform by Baird, Longboard Takeover Cited
Baird Initiates Bright Minds Biosciences(DRUG.US) With Buy Rating, Announces Target Price $75
Bright Minds Biosciences: Promising Pipeline and Strategic Positioning Justify Buy Rating
Baird Initiates Coverage On Bright Minds Biosciences With Outperform Rating, Announces Price Target of $75
Bright Minds Biosciences Analyst Ratings
Meet the Biotech Stock That Has Generated Nvidia-Like Returns in Less Than a Month
No Data